• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病中免疫调节的未来方向:以帕金森病为例。

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.

机构信息

Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA.

出版信息

J Neural Transm (Vienna). 2010 Aug;117(8):1019-25. doi: 10.1007/s00702-010-0431-6. Epub 2010 Jun 12.

DOI:10.1007/s00702-010-0431-6
PMID:20549523
Abstract

One common feature of neurodegenerative diseases is neuroinflammation. In the case of Parkinson's disease (PD), neuroinflammation appears early and persists throughout the disease course. The principal cellular mediator of brain inflammation is the resident microglia which share many features with related hematopoietically derived macrophages. Microglia can become activated by misfolded proteins including the PD relevant example, alpha-synuclein, a presynaptic protein. When activated, microglia release pro-inflammatory diffusible mediators that promote dysfunction and contribute to the death of the PD vulnerable dopaminergic neurons in the midbrain. Recently, the orphan nuclear receptor Nurr1, well known as a critical determinant in dopaminergic neuron maturation, has been ascribed two new properties. First, it promotes the production and release of the neuropeptide vasoactive intestinal peptide that functions both to stimulate dopaminergic neuron survival and inhibit neuroinflammation. Second, Nurr1 suppresses the expression and release of pro-inflammatory cytokines in glial cells. Herein, we discuss these new findings in context of strategies to attenuate neuroinflammation in PD.

摘要

神经退行性疾病的一个共同特征是神经炎症。在帕金森病(PD)中,神经炎症似乎很早就出现了,并贯穿整个疾病过程。大脑炎症的主要细胞介质是驻留的小胶质细胞,它与相关的造血衍生的巨噬细胞有许多共同特征。小胶质细胞可以被包括 PD 相关的α-突触核蛋白在内的错误折叠蛋白激活,α-突触核蛋白是一种突触前蛋白。当被激活时,小胶质细胞释放促炎的可扩散介质,促进功能障碍,并导致中脑 PD 易损的多巴胺能神经元死亡。最近,孤儿核受体 Nurr1 作为多巴胺能神经元成熟的关键决定因素,被赋予了两个新的特性。首先,它促进神经肽血管活性肠肽的产生和释放,该肽具有刺激多巴胺能神经元存活和抑制神经炎症的双重作用。其次,Nurr1 抑制神经胶质细胞中促炎细胞因子的表达和释放。在此,我们将这些新发现置于减轻 PD 中神经炎症的策略背景下进行讨论。

相似文献

1
Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.神经退行性疾病中免疫调节的未来方向:以帕金森病为例。
J Neural Transm (Vienna). 2010 Aug;117(8):1019-25. doi: 10.1007/s00702-010-0431-6. Epub 2010 Jun 12.
2
Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.谷氧还蛋白-1的上调激活小胶质细胞并促进神经退行性变:对帕金森病的影响
Antioxid Redox Signal. 2016 Dec 20;25(18):967-982. doi: 10.1089/ars.2015.6598. Epub 2016 Jun 27.
3
Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.NURR1 调控的神经炎症在帕金森病中的作用研究进展。
Int J Mol Sci. 2022 Dec 19;23(24):16184. doi: 10.3390/ijms232416184.
4
The role of neuroinflammation on the pathogenesis of Parkinson's disease.神经炎症在帕金森病发病机制中的作用。
BMB Rep. 2010 Apr;43(4):225-32. doi: 10.5483/bmbrep.2010.43.4.225.
5
Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease.Nur(R1)turing 一个关于帕金森病发病机制的概念。
Neurotox Res. 2009 Oct;16(3):261-70. doi: 10.1007/s12640-009-9056-7. Epub 2009 Apr 24.
6
Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.小胶质细胞,脑部炎症的主要参与者:它们在帕金森病发病机制中的作用。
Exp Mol Med. 2006 Aug 31;38(4):333-47. doi: 10.1038/emm.2006.40.
7
Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?帕金森病中的神经炎症:基于机制的介入治疗是否有充分证据?
Front Biosci. 2008 Jan 1;13:709-17. doi: 10.2741/2713.
8
Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.针对神经炎症的帕金森病的病理机制特征分析及潜在治疗药物的鉴定。
Int J Mol Sci. 2021 Jan 21;22(3):1062. doi: 10.3390/ijms22031062.
9
Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets.神经炎症反应与帕金森病:发病机制与治疗靶点。
J Neuroimmune Pharmacol. 2020 Dec;15(4):830-837. doi: 10.1007/s11481-020-09926-7. Epub 2020 Jun 11.
10
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.抑制JAK/STAT信号通路可预防α-突触核蛋白诱导的神经炎症和多巴胺能神经退行性变。
J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.

引用本文的文献

1
New Insights on the Potential Role of Pyroptosis in Parkinson's Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics.焦亡在帕金森神经病理学中的潜在作用及基于纳米颗粒的miRNA治疗学最新进展对NLRP3炎性小体的治疗靶向的新见解
Mol Neurobiol. 2025 Mar 18. doi: 10.1007/s12035-025-04818-4.
2
Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders.褪黑素与健康:褪黑素作用、生物学功能及相关疾病的洞察。
Cell Mol Neurobiol. 2023 Aug;43(6):2437-2458. doi: 10.1007/s10571-023-01324-w. Epub 2023 Feb 8.
3
Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation.

本文引用的文献

1
Neuroinflammation in the living brain of Parkinson's disease.帕金森病患者活体大脑中的神经炎症。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S200-4. doi: 10.1016/S1353-8020(09)70814-4.
2
Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.α-突触核蛋白从神经元直接转移到星形胶质细胞会导致突触核蛋白病中的炎症反应。
J Biol Chem. 2010 Mar 19;285(12):9262-72. doi: 10.1074/jbc.M109.081125. Epub 2010 Jan 13.
3
Microglia: biology and pathology.小胶质细胞:生物学与病理学。
大麻二酚通过靶向 WNT/β-连环蛋白通路、氧化应激和炎症在帕金森病中的潜在作用。
Aging (Albany NY). 2021 Apr 13;13(7):10796-10813. doi: 10.18632/aging.202951.
4
Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway.帕金森病:通过靶向 WNT/β-连环蛋白通路、氧化应激、炎症和谷氨酸能通路,锂的潜在作用。
Cells. 2021 Jan 25;10(2):230. doi: 10.3390/cells10020230.
5
Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.昼夜节律、神经炎症和氧化应激在帕金森病中的故事。
Cells. 2020 Jan 28;9(2):314. doi: 10.3390/cells9020314.
6
Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence.褪黑素作为神经保护剂在啮齿动物模型中的药理作用:当前生物学证据的综述。
Cell Mol Neurobiol. 2020 Jan;40(1):25-51. doi: 10.1007/s10571-019-00724-1. Epub 2019 Aug 21.
7
Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.神经退行性疾病中的热力学:经典 WNT/β-连环蛋白通路-PPARγ、能量代谢和昼夜节律的相互作用。
Neuromolecular Med. 2018 Jun;20(2):174-204. doi: 10.1007/s12017-018-8486-x. Epub 2018 Mar 23.
8
The neuroprotective role of melatonin in neurological disorders.褪黑素在神经紊乱中的神经保护作用。
J Neurosci Res. 2018 Jul;96(7):1136-1149. doi: 10.1002/jnr.24220. Epub 2018 Mar 1.
9
Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.炎症改变背侧纹状体 D2 但不改变 D1 棘突投射神经元中 AMPA 刺激的钙反应。
Eur J Neurosci. 2017 Nov;46(9):2519-2533. doi: 10.1111/ejn.13711. Epub 2017 Oct 10.
10
Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.在帕金森病小鼠模型中,嘌呤吗啡激活音猬因子信号,通过介导PI3K/AKt信号通路保护多巴胺能神经元并减轻炎症反应。
Mol Med Rep. 2017 Aug;16(2):1269-1277. doi: 10.3892/mmr.2017.6751. Epub 2017 Jun 9.
Acta Neuropathol. 2010 Jan;119(1):89-105. doi: 10.1007/s00401-009-0622-0. Epub 2009 Dec 13.
4
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.全基因组关联研究确定了四个位点的常见变异为帕金森病的遗传风险因素。
Nat Genet. 2009 Dec;41(12):1303-7. doi: 10.1038/ng.485. Epub 2009 Nov 15.
5
Genome-wide association study reveals genetic risk underlying Parkinson's disease.全基因组关联研究揭示帕金森病的遗传风险。
Nat Genet. 2009 Dec;41(12):1308-12. doi: 10.1038/ng.487. Epub 2009 Nov 15.
6
Non-motor symptoms may herald Parkinson's disease.非运动症状可能是帕金森病的先兆。
Practitioner. 2009 Sep;253(1721):19-24, 2.
7
Brainstem pathology and non-motor symptoms in PD.脑干部位病理学与 PD 的非运动症状。
J Neurol Sci. 2010 Feb 15;289(1-2):81-8. doi: 10.1016/j.jns.2009.08.021. Epub 2009 Sep 15.
8
Mutant alpha-synuclein overexpression mediates early proinflammatory activity.突变的α-突触核蛋白过表达介导早期的促炎活性。
Neurotox Res. 2009 Oct;16(3):238-54. doi: 10.1007/s12640-009-9053-x. Epub 2009 Apr 28.
9
Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease.Nur(R1)turing 一个关于帕金森病发病机制的概念。
Neurotox Res. 2009 Oct;16(3):261-70. doi: 10.1007/s12640-009-9056-7. Epub 2009 Apr 24.
10
[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?[11C]-PK11195 PET:帕金森病神经炎症的定量评估及抗炎治疗的监测?
Parkinsonism Relat Disord. 2010 Jan;16(1):57-9. doi: 10.1016/j.parkreldis.2009.05.005. Epub 2009 May 31.